WHERE DO WE GO FROM HERE? BEYOND THE NEJM MAGNASAFE TRIAL: A FOCUS BEYOND A MYOPIC CMR ‘SAFETY-FIRST’ NOTION

MLA

Loretta Gevenosky, et al. “Where Do We Go from Here? Beyond the Nejm Magnasafe Trial: A Focus beyond a Myopic Cmr ‘Safety-First’ Notion.” Journal of the American College of Cardiology, vol. 71, Mar. 2018, p. A487. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........f443fa03e3c3e1fab504a7cc94fd6e75&authtype=sso&custid=ns315887.

APA

Loretta Gevenosky, Ronald B Williams, Robert W Biederman, Huma Samar, Mark Doyle, Christopher Bonnet, Moneal Shah, & Richard Lombardi. (2018). Where Do We Go from Here? Beyond the Nejm Magnasafe Trial: A Focus beyond a Myopic Cmr ‘Safety-First’ Notion. Journal of the American College of Cardiology, 71, A487.

Chicago

Loretta Gevenosky, Ronald B Williams, Robert W Biederman, Huma Samar, Mark Doyle, Christopher Bonnet, Moneal Shah, and Richard Lombardi. 2018. “Where Do We Go from Here? Beyond the Nejm Magnasafe Trial: A Focus beyond a Myopic Cmr ‘Safety-First’ Notion.” Journal of the American College of Cardiology 71 (March): A487. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........f443fa03e3c3e1fab504a7cc94fd6e75&authtype=sso&custid=ns315887.